Manhong Wu1, Yue Xu2, William L Fitch1, Ming Zheng1, Robert E Merritt2, Joseph B Shrager2,3, Weiruo Zhang4, David L Dill4, Gary Peltz1, Chuong D Hoang2,3. 1. Department of Anesthesia, Stanford University School of Medicine. 2. Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine. 3. Section of Thoracic Surgery, Veterans Affairs Palo Alto Health Care System. 4. Department of Computer Science, Stanford University School of Engineering.
Abstract
RATIONALE: Metabolomic profiling is a promising methodology of identifying candidate biomarkers for disease detection and monitoring. Although lung cancer is among the leading causes of cancer-related mortality worldwide, the lung tumor metabolome has not been fully characterized. METHODS: We utilized a targeted metabolomic approach to analyze discrete groups of related metabolites. We adopted a dansyl [5-(dimethylamino)-1-naphthalene sulfonamide] derivatization with liquid chromatography/mass spectrometry (LC/MS) to analyze changes of metabolites from paired tumor and normal lung tissues. Identification of dansylated dipeptides was confirmed with synthetic standards. A systematic analysis of retention times was required to reliably identify isobaric dipeptides. We validated our findings in a separate sample cohort. RESULTS: We produced a database of the LC retention times and MS/MS spectra of 361 dansyl dipeptides. Interpretation of the spectra is presented. Using this standard data, we identified a total of 279 dipeptides in lung tumor tissue. The abundance of 90 dipeptides was selectively increased in lung tumor tissue compared to normal tissue. In a second set of validation tissues, 12 dipeptides were selectively increased. CONCLUSIONS: A systematic evaluation of certain metabolite classes in lung tumors may identify promising disease-specific metabolites. Our database of all possible dipeptides will facilitate ongoing translational applications of metabolomic profiling as it relates to lung cancer.
RATIONALE: Metabolomic profiling is a promising methodology of identifying candidate biomarkers for disease detection and monitoring. Although lung cancer is among the leading causes of cancer-related mortality worldwide, the lung tumor metabolome has not been fully characterized. METHODS: We utilized a targeted metabolomic approach to analyze discrete groups of related metabolites. We adopted a dansyl [5-(dimethylamino)-1-naphthalene sulfonamide] derivatization with liquid chromatography/mass spectrometry (LC/MS) to analyze changes of metabolites from paired tumor and normal lung tissues. Identification of dansylated dipeptides was confirmed with synthetic standards. A systematic analysis of retention times was required to reliably identify isobaric dipeptides. We validated our findings in a separate sample cohort. RESULTS: We produced a database of the LC retention times and MS/MS spectra of 361 dansyl dipeptides. Interpretation of the spectra is presented. Using this standard data, we identified a total of 279 dipeptides in lung tumor tissue. The abundance of 90 dipeptides was selectively increased in lung tumor tissue compared to normal tissue. In a second set of validation tissues, 12 dipeptides were selectively increased. CONCLUSIONS: A systematic evaluation of certain metabolite classes in lung tumors may identify promising disease-specific metabolites. Our database of all possible dipeptides will facilitate ongoing translational applications of metabolomic profiling as it relates to lung cancer.
Authors: Warwick B Dunn; David Broadhurst; Paul Begley; Eva Zelena; Sue Francis-McIntyre; Nadine Anderson; Marie Brown; Joshau D Knowles; Antony Halsall; John N Haselden; Andrew W Nicholls; Ian D Wilson; Douglas B Kell; Royston Goodacre Journal: Nat Protoc Date: 2011-06-30 Impact factor: 13.491
Authors: Isabelle M Frey; Isabel Rubio-Aliaga; Anne Siewert; Daniela Sailer; Aleksey Drobyshev; Johannes Beckers; Martin Hrabé de Angelis; Julie Aubert; Avner Bar Hen; Oliver Fiehn; Hans M Eichinger; Hannelore Daniel Journal: Physiol Genomics Date: 2006-10-31 Impact factor: 3.107
Authors: Teresa W-M Fan; Andrew N Lane; Richard M Higashi; Michael Bousamra; Goetz Kloecker; Donald M Miller Journal: Exp Mol Pathol Date: 2009-05-03 Impact factor: 3.362
Authors: David S Wishart; Dan Tzur; Craig Knox; Roman Eisner; An Chi Guo; Nelson Young; Dean Cheng; Kevin Jewell; David Arndt; Summit Sawhney; Chris Fung; Lisa Nikolai; Mike Lewis; Marie-Aude Coutouly; Ian Forsythe; Peter Tang; Savita Shrivastava; Kevin Jeroncic; Paul Stothard; Godwin Amegbey; David Block; David D Hau; James Wagner; Jessica Miniaci; Melisa Clements; Mulu Gebremedhin; Natalie Guo; Ying Zhang; Gavin E Duggan; Glen D Macinnis; Alim M Weljie; Reza Dowlatabadi; Fiona Bamforth; Derrick Clive; Russ Greiner; Liang Li; Tom Marrie; Brian D Sykes; Hans J Vogel; Lori Querengesser Journal: Nucleic Acids Res Date: 2007-01 Impact factor: 16.971
Authors: Anne J Kleinnijenhuis; Frédérique L van Holthoon; Annet J H Maathuis; Barbara Vanhoecke; Janne Prawitt; Fabien Wauquier; Yohann Wittrant Journal: Anal Bioanal Chem Date: 2019-12-24 Impact factor: 4.142
Authors: Agnieszka B Wegrzyn; Katharina Herzog; Albert Gerding; Marcel Kwiatkowski; Justina C Wolters; Amalia M Dolga; Alida E M van Lint; Ronald J A Wanders; Hans R Waterham; Barbara M Bakker Journal: FEBS J Date: 2020-03-31 Impact factor: 5.542
Authors: Andres Sánchez-Kopper; Max Becker; Jennifer Pfizenmaier; Christian Kessler; Andreas Karau; Ralf Takors Journal: AMB Express Date: 2016-07-22 Impact factor: 3.298